What happened in optometry this week: March 11 - March 15

Blog
Article

Catch up on what happened in optometry during the week of March 11-March 15.

Catch up with what Optometry Times shared this week:

Phase 2b trial complete for OAG drug-eluting contact lens from MediPrint Ophthalmics

By Martin David Harp, Associate Editor, Ophthalmology Times

MediPrint Ophthalmics has announced the completion of its glaucoma SIGHT-2, phase 2b study evaluating their LL-BMT1 versus a control group on bimatoprost 0.01% ophthalmic solution. The active-controlled, randomized, dose-finding, multi-center study evaluated the safety and efficacy of LL-BMT1 in 28 patients diagnosed with open-angle glaucoma for 3 weeks.

Read here...

Lessons learned from COVID-19: How to prepare for the next public health emergency

By Cynthia P. Ruggeiro, OD, MPH, FAAO, and Heidi Sutter, OD, MPH

Since its emergence in late 2019, the SARS-CoV-2 virus has changed lives and livelihoods and raised our awareness of the potential for circulating pathogens to disrupt our world. Although COVID-19 is still with us, we are removed enough from the early days of widespread uncertainty to start assessing what we have learned.

Read here...

Turning inexperience into expertise in fitting scleral lenses

By Jeffrey Sonsino, OD, FAAO, and Julie Lafreniere, OD, FAAO

Scleral lenses demand expertise. We can cause real harm by placing a hard piece of plastic on soft tissue. Although they require time to fit and are difficult to troubleshoot when problems arise, scleral lenses are life-changing for our patients.

Read here...

You and Eye: What optometrists need to know about low vision

By Miriam Korik, OD, and Emily Kaiser Maharjan, Assistant Managing Editor

Patrick D. Yoshinaga, OD, MPH, FAAO, professor and chief of low vision rehabilitation service at Southern California College of Optometry at Marshall B. Ketchum University joins host Miriam Korik, OD, on a deep dive into what low vision rehab entails. Assistive tech, diagnosis, occupational therapy referrals, and AI–all and more are discussed as these two experts discuss the the big picture and minutia of care for patients with low vision.

Listen here...

Organizations planning ahead with resources for total solar eclipse

By Jordana Joy, Associate Editor

A handful of organizations are already prepping for the April 8 total solar eclipse.

Prevent Blindness will be utilizing its Eclipse + Your Eyes program, which includes educational videos, materials, and toolkits for the public.1 Additionally, the American Optometric Association (AOA) is supplying materials for its member doctors and posting eye safety information to help keep the public's eyes healthy during the event.2

Read here...

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Presenters from the Collaborative Care Symposium 2025 give their key takeaways from their presentations.
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
© 2025 MJH Life Sciences

All rights reserved.